en

PRODUCT DETAIL

Onglyza 2,5 mg filmom obalené tablety

Code 07609
MA number EU/1/09/545/012
Product Form: tbl flm 28x2,5 mg (blister Al/Al, neperfor., kalend.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
MAH, country: AstraZeneca AB, Sweden
Therapeutic Class: 18 - ANTIDIABETICA (VRÁTANE INZULÍNU)
ATC:
A ALIMENTARY TRACT AND METABOLISM
A10 DRUGS USED IN DIABETES
A10B Blood glucose lowering drugs, excl. insulins
A10BH Dipeptidyl peptidase 4 (DPP-4) inhibitors
A10BH03 Saxagliptin
Shelf life: 36
Container: blister Al/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 28.02.2011
SmPC + PL: European Medicines Agency's database
Dokument: DHCP Onglyza 8 3 2012.pdf  
Safety feature Yes
Data update: 19.06.2018
eu-flag.png sk-flag.png